MINA (HOLDINGS) LIMITED
Get an alert when MINA (HOLDINGS) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£67k
-92.2% lowest in 3 filed years
Net assets
-£8.6m
-2% lowest in 3 filed years
Employees
30
-9.1% lowest in 3 filed years
Profit before tax
-£5.6m
+43.6% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
At the date of the issuance of these financial statements, the Company estimates that it has approximately 11 months of cash on hand and expected to be received shortly, and therefore it does not have sufficient to fund its operations for the next 12 months to 30 June 2027. While the Company anticipates the achievement of certain milestone payments relating to its ongoing collaborations, these cannot be certain.
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
-
Going-concern uncertainty disclosed
-
Negative shareholders' funds
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £4,678,682 | £1,550,529 | £1,770,724 | +14.2% | |
| Operating profit | -£7,803,032 | -£8,545,120 | -£4,271,572 | +50% | |
| Profit before tax | -£9,033,302 | -£9,866,127 | -£5,564,009 | +43.6% | |
| Net profit | -£7,506,260 | -£8,548,649 | -£4,342,885 | +49.2% | |
| Cash | £5,470,015 | £861,193 | £67,423 | -92.2% | |
| Total assets less current liabilities | £2,770,260 | -£3,455,141 | -£5,135,194 | -48.6% | |
| Net assets | -£3,563,210 | -£8,469,165 | -£8,637,710 | -2% | |
| Equity | -£3,563,210 | — | — | — | |
| Average employees | 34 | 33 | 30 | -9.1% | |
| Wages | £3,459,726 | £2,431,364 | £2,492,663 | +2.5% | |
| Directors' remuneration | £721,822 | £644,001 | £509,201 | -20.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -166.8% | — | — | |
| Net margin | -160.4% | — | — | |
| Return on capital employed | -281.7% | — | — | |
| Gearing (liabilities / total assets) | 133.5% | 247.8% | 264.8% | |
| Current ratio | 1.24x | 0.52x | 0.43x | |
| Interest cover | -6.30x | -6.40x | -3.30x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Material uncertainty disclosed
“At the date of the issuance of these financial statements, the Company estimates that it has approximately 11 months of cash on hand and expected to be received shortly, and therefore it does not have sufficient to fund its operations for the next 12 months to 30 June 2027. While the Company anticipates the achievement of certain milestone payments relating to its ongoing collaborations, these cannot be certain.”
Group structure
- MINA (HOLDINGS) LIMITED · parent
- MINA Therapeutics Limited 100%
- MINA Alpha Limited 100%
- MINA Beta Limited 100%
- MINA Therapeutics Denmark ApS 100%
Significant events
- “The Company repaid and borrowed short-term bridge funding under certain credit advance agreements with Bootstrap Europe S.À.R.L and KF Business Ventures, LP. In addition the Company issued $2,100,000 in convertible loan notes.”
- “On 8 January 2026 the Group repaid £1,060,081 to Bootstrap Europe 3.0 S.À.R.L and KF Business Ventures, LP to satisfy the first and second credit advance agreements.”
- “On 25 February 2026 the Group borrowed a further £270,000 pursuant to the third credit advance agreement with Bootstrap Europe 3.0 S.À.R.L and KF Business Ventures, LP.”
- “On 24 March 2026 the Group borrowed £140,000 pursuant to a fourth credit advance agreement with KF Business Ventures, LP which was repaid with fees on 9 April 2026.”
- “On 30 March 2026 the Company issued $2,100,000 in convertible loan notes to Libreville Africa Holdings Limited, an investment vehicle affiliated with the Fund For Export Development In Africa.”
- “On 27 March 2026 Group was awarded by HMRG an R&D tax credit including accrued interest of £1,045,525.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BAINS, Peter James Jonathan | Director | 2014-12-17 | Jul 1957 | British |
| BISCHOFBERGER, Norbert Wolfgang, Dr. | Director | 2025-03-17 | Jan 1956 | American |
| CLEMENT-DAVIES, Susan Elizabeth | Director | 2022-01-01 | Jul 1962 | British |
| GALANTINE-HELLER, Stephanie | Director | 2025-02-17 | Mar 1983 | French |
| HABIB, Robert Sebastian | Director | 2014-11-03 | Nov 1985 | British |
| KOPPLE, Robert Charles | Director | 2014-12-17 | Mar 1944 | American |
| LECHLER, Robert Ian, Sir | Director | 2022-01-01 | Dec 1951 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COHEN, Yael Gruenbaum, Dr. | Director | 2025-02-17 | 2025-11-10 |
| HABIB, Nagy, Professor | Director | 2014-12-17 | 2023-03-01 |
| JOHNSON, Kieran Roy Darren | Director | 2019-05-15 | 2022-10-13 |
| ROSHWALB, Gur-Arye, Dr. | Director | 2020-08-04 | 2024-07-10 |
| SCHINDEL, Yair Chaim, Dr | Director | 2024-07-29 | 2025-02-17 |
| WOOD, Christopher Barry, Prof | Director | 2014-12-17 | 2023-03-01 |
| OVAL NOMINEES LIMITED | Corporate Director | 2014-11-03 | 2014-11-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Stephanie Galantine-Heller | Individual | Shares 25–50%, Voting 25–50% | 2025-02-17 | Active |
| Robert Charles Kopple | Individual | Shares 25–50%, Voting 25–50% | 2025-02-17 | Active |
| Dr Yair Chaim Schindel | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-09-08 | Ceased 2025-02-17 |
| Heptares Therapeutics Limited | Corporate entity | Voting 25–50% | 2018-11-29 | Ceased 2020-08-04 |
| Sosei R&D Limited | Corporate entity | Voting 25–50% | 2017-05-02 | Ceased 2018-11-29 |
Filing timeline
Last 20 of 123 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-03-07 MA Memorandum articles
- 2025-03-07 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-25 | AA | accounts | Accounts with accounts type group | |
| 2026-03-10 | SH01 | capital | Capital allotment shares | |
| 2026-01-05 | CH01 | officers | Change person director company with change date | |
| 2025-12-27 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-12-24 | SH01 | capital | Capital allotment shares | |
| 2025-12-24 | CH01 | officers | Change person director company with change date | |
| 2025-12-24 | CH01 | officers | Change person director company with change date | |
| 2025-12-24 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-12-18 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-28 | AA | accounts | Accounts with accounts type group | |
| 2025-06-26 | SH01 | capital | Capital allotment shares | |
| 2025-05-28 | AA | accounts | Accounts with accounts type total exemption full | |
| 2025-03-25 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-03-25 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-03-21 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-21 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2025-03-07 | MA | incorporation | Memorandum articles | |
| 2025-03-07 | RESOLUTIONS | resolution | Resolution | |
| 2025-03-05 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 10
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.